Historically, health plans have viewed readmissions primarily as an indicator for quality and performance, but that idea is shifting. Recent policy changes have expanded how readmissions are measured and evaluated across Medicare populations.
These changes have placed a spotlight on utilization patterns, and health plans are now realizing readmissions can also be a financial and operational concern.
While these changes expand readmissions measurement to Medicare Advantage populations, CMS has not yet incorporated Medicare Advantage payment data into readmission penalty calculations.
As these concerns are surfacing, many health plans are choosing to examine readmissions earlier in the claim lifecycle, where utilization and payment risks can be proactively identified and addressed.